Anti-SAA1 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22106; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-SAA1 Polyclonal Antibody: A Powerful Tool for Biotech Research
The Anti-SAA1 Polyclonal Antibody is a highly specific and reliable tool for biotech research. This antibody is specifically designed to target the Serum Amyloid A1 (SAA1) protein, a key biomarker in various inflammatory diseases. With its superior sensitivity and specificity, this antibody is an essential tool for studying the role of SAA1 in disease progression and developing potential treatments.
SAA1 is an acute-phase protein that is produced in response to inflammation and tissue injury. It plays a crucial role in the body’s immune response and is involved in the pathogenesis of various inflammatory diseases, such as rheumatoid arthritis, atherosclerosis, and cancer. The Anti-SAA1 Polyclonal Antibody binds to SAA1 with high affinity, allowing for accurate detection and measurement of SAA1 levels in biological samples.
The Anti-SAA1 Polyclonal Antibody is widely used in research applications, including ELISA, Western blotting, immunohistochemistry, and flow cytometry. It has been validated for use in human, mouse, and rat samples, making it a versatile tool for a wide range of studies. This antibody is also suitable for both in vitro and in vivo experiments, providing researchers with flexibility and convenience in their research.
The Anti-SAA1 Polyclonal Antibody has been used in numerous studies to investigate the role of SAA1 in various diseases. For example, it has been used to measure SAA1 levels in patients with rheumatoid arthritis, providing valuable insights into the disease progression and response to treatment. Additionally, this antibody has been used to study the impact of SAA1 on atherosclerosis development and to identify potential therapeutic targets for this condition.
In conclusion, the Anti-SAA1 Polyclonal Antibody is a highly specific and sensitive tool for studying the role of SAA1 in inflammatory diseases. Its versatility and reliability make it an essential tool for biotech research, providing valuable insights and contributing to the development of potential treatments. Trust in this antibody for accurate and reproducible results in your research. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22106. For research use only.
Target: Serum amyloid A protein; SAA; Amyloid protein A; Amyloid fibril protein AA; SAA1; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Serum amyloid A protein; SAA; Amyloid protein A; Amyloid fibril protein AA; SAA1 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
